Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atopic Healthy Subjects”

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05932888
What this trial is testing

Safety, Tolerability, and Pharmacokinetic Study of QLM3003 in Healthy Adult Subjects

Who this might be right for
Atopic Dermatitis
Qilu Pharmaceutical Co., Ltd. 40
Early research (Phase 1)Study completedNCT06268860
What this trial is testing

Assess Bioavailability of Rocatinlimab (AMG 451) Vial and Prefilled Syringe in Healthy Participants

Who this might be right for
Atopic Dermatitis
Amgen 240
Early research (Phase 1)Ended earlyNCT04211415
What this trial is testing

Phase I Study of DS-2741a in Healthy Volunteers and Participants With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Daiichi Sankyo Co., Ltd. 8
Early research (Phase 1)Study completedNCT07533851
What this trial is testing

A Food Effect Study of VC005 Tablets in Healthy Adult Subjects.

Who this might be right for
Atopic Dermatitis
Jiangsu vcare pharmaceutical technology co., LTD 31
Early research (Phase 1)UnknownNCT05409326
What this trial is testing

TQH2722 Injection to Evaluate the Safety, Tolerability, Pharmacokinetics, Efficacy and Immunogenicity in Healthy Adult Subjects

Who this might be right for
Atopic Dermatitis
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 48
Early research (Phase 1)Study completedNCT01614756
What this trial is testing

A Two-Part, Phase 1, Single-Dose Study of IL-31 mAb (Anti-Interleukin 31 Monoclonal Antibody); in Healthy Subjects and Adults With Atopic Dermatitis

Who this might be right for
Healthy Subjects and Atopic Dermatitis Subjects
Bristol-Myers Squibb 93
Early research (Phase 1)Not Yet RecruitingNCT07801612
What this trial is testing

A Phase I Study of HXN5003 in Healthy Participants and Patients With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Health Adult SubjectsModerate-to-Severe Atopic Dermatitis
Helixon Biotechnology (Suzhou) Co., Ltd 68
Early research (Phase 1)UnknownNCT03819881
What this trial is testing

A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy

Who this might be right for
Atopic Immunoglobulin E-Mediated Allergic Disorder
Siolta Therapeutics, Inc. 60
Early research (Phase 1)Study completedNCT02345928
What this trial is testing

A Single Ascending Dose Study in Healthy Participants and Multiple Ascending Dose Study of CNTO 7160 in Participants With Asthma and Participants With Atopic Dermatitis

Who this might be right for
AsthmaAtopic DermatitisHealthy
Janssen Research & Development, LLC 108
Early research (Phase 1)Study completedNCT03733353
What this trial is testing

EDP1815 in Healthy Participants and Participants With Mild to Moderate Psoriasis and Atopic Dermatitis

Who this might be right for
PsoriasisAtopic Dermatitis
Evelo Biosciences, Inc. 204
Early research (Phase 1)Looking for participantsNCT07239947
What this trial is testing

BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Bambusa Therapeutics 99
Early research (Phase 1)Study completedNCT07103369
What this trial is testing

A Phase I Clinical Study to Evaluate SM17 in Chinese Healthy Subjects and Patients With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
SinoMab BioScience Ltd 64
Early research (Phase 1)Study completedNCT06193434
What this trial is testing

A First In Human (FIH) Study of IBI356 in Healthy Participants and in Atopic Dermatitis Patients

Who this might be right for
Healthy ParticipantsAtopic Dermatitis Patients
Innovent Biologics (Suzhou) Co. Ltd. 99
Early research (Phase 1)Looking for participantsNCT06808477
What this trial is testing

BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Bambusa Therapeutics 237
Early research (Phase 1)Looking for participantsNCT07453602
What this trial is testing

Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234

Who this might be right for
Atopic Dermatitis (AD)Eczema
Arcutis Biotherapeutics, Inc. 125
Large-scale testing (Phase 3)Study completedNCT02132169
What this trial is testing

A Multi-Center Study Evaluating the Safety of AC-170 0.24%

Who this might be right for
Atopic Disease (Including Allergic Conjunctivitis)
Aciex Therapeutics, Inc. 512
Early research (Phase 1)Study completedNCT00958516
What this trial is testing

Assessment of the Phototoxic Potential of LEO 29102 Cream

Who this might be right for
Atopic Dermatitis
LEO Pharma 32
Early research (Phase 1)Not Yet RecruitingNCT07549750
What this trial is testing

A Dose Escalation Phase 1 Study of HXN5003 in Healthy Participants

Who this might be right for
Atopic Dermatitis
Helixon Biotechnology (Suzhou) Co., Ltd 28
Early research (Phase 1)Ended earlyNCT05859724
What this trial is testing

Evaluation of NM26-2198 in Healthy Subjects and in Patients With Moderate-to-severe Atopic Dermatitis (AD)

Who this might be right for
Atopic Dermatitis
Yellow Jersey Therapeutics AG 126
Not applicableStudy completedNCT06934980
What this trial is testing

Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants

Who this might be right for
Atopic DermatitisHealthy Volunteers
Incyte Corporation 20
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation